A. Hervás

1.3k total citations
54 papers, 807 citations indexed

About

A. Hervás is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A. Hervás has authored 54 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 15 papers in Surgery. Recurrent topics in A. Hervás's work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (20 papers) and Advanced Radiotherapy Techniques (8 papers). A. Hervás is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (20 papers) and Advanced Radiotherapy Techniques (8 papers). A. Hervás collaborates with scholars based in Spain, United States and Australia. A. Hervás's co-authors include Víctor Macías, Ismael Herruzo, Alfonso Mariño, Montse Ferrer, María José Ortiz, Ferrán Guedea, José Francisco Suárez, Ferrán Aguiló, Gemma Sancho and Pablo Fernández and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. Hervás

47 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hervás Spain 14 503 263 204 146 76 54 807
Alfonso Mariño Spain 11 389 0.8× 130 0.5× 171 0.8× 99 0.7× 59 0.8× 18 609
Gemma Sancho Spain 14 414 0.8× 159 0.6× 114 0.6× 150 1.0× 121 1.6× 47 746
Jonn Wu Canada 17 510 1.0× 243 0.9× 247 1.2× 248 1.7× 260 3.4× 61 1.0k
John W. Colberg United States 18 548 1.1× 108 0.4× 252 1.2× 147 1.0× 43 0.6× 35 970
L. Cormier France 21 822 1.6× 241 0.9× 406 2.0× 95 0.7× 138 1.8× 90 1.3k
P. Kil Netherlands 16 954 1.9× 252 1.0× 348 1.7× 181 1.2× 106 1.4× 36 1.3k
S. Guérif France 16 1.0k 2.1× 375 1.4× 237 1.2× 465 3.2× 200 2.6× 65 1.5k
Ewa Szumacher Canada 15 415 0.8× 100 0.4× 110 0.5× 250 1.7× 86 1.1× 43 626
Göran Borghede Sweden 13 408 0.8× 322 1.2× 360 1.8× 139 1.0× 66 0.9× 18 857
Mark S. Austenfeld United States 12 518 1.0× 144 0.5× 229 1.1× 44 0.3× 41 0.5× 17 762

Countries citing papers authored by A. Hervás

Since Specialization
Citations

This map shows the geographic impact of A. Hervás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hervás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hervás more than expected).

Fields of papers citing papers by A. Hervás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hervás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hervás. The network helps show where A. Hervás may publish in the future.

Co-authorship network of co-authors of A. Hervás

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hervás. A scholar is included among the top collaborators of A. Hervás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hervás. A. Hervás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hervás, A., et al.. (2023). The use of a thin guide‐wire for urethral definition in prostate SBRT treatments with Cyberknife. Journal of Applied Clinical Medical Physics. 24(8). e14006–e14006. 1 indexed citations
2.
Lara, Pedro C., Amalia Palacios, A. Hervás, et al.. (2022). Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer. Frontiers in Oncology. 12. 891886–891886. 3 indexed citations
3.
Conde-Moreno, Antonio J., Fernando Durán López, A. Hervás, et al.. (2021). Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 111(3). S59–S59. 7 indexed citations
4.
Garín, Olatz, José Francisco Suárez, Ferrán Guedea, et al.. (2020). Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study. International Journal of Radiation Oncology*Biology*Physics. 110(3). 718–726. 8 indexed citations
5.
López‐Campos, Fernando, Virgilia Macias, Antonio J. Conde-Moreno, et al.. (2019). Time for radioimmunotherapy: an overview to bring improvements in clinical practice. Clinical & Translational Oncology. 21(8). 992–1004. 15 indexed citations
6.
Martín, M., et al.. (2019). Magnetic Resonance Imaging Value to Predict Pathologic Staging in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation. SHILAP Revista de lepidopterología. 29(1). 39–45. 1 indexed citations
7.
Hervás, A., Carlos González, Josep Jové, et al.. (2018). Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database. Clinical & Translational Oncology. 21(7). 900–909. 3 indexed citations
8.
Moreno, Víctor, Marta Gil-Martín, Melissa L. Johnson, et al.. (2018). MA04.01 Cemiplimab, a Human Monoclonal Anti-PD-1, Alone or in Combination with Radiotherapy: Phase 1 NSCLC Expansion Cohorts. Journal of Thoracic Oncology. 13(10). S366–S366. 14 indexed citations
9.
Moreno, Víctor, Marta Gil-Martín, Melissa L. Johnson, et al.. (2018). Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2). Annals of Oncology. 29. viii414–viii414. 3 indexed citations
10.
Hervás, A., Antonio Gómez‐Caamaño, Alfonso Gómez‐Iturriaga, et al.. (2017). Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database. Clinical & Translational Oncology. 20(2). 193–200. 5 indexed citations
11.
Casas, Francesc, I. Henrı́quez, Xavier Maldonado, et al.. (2016). Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study. Clinical & Translational Oncology. 19(3). 373–378. 5 indexed citations
12.
Gómez‐Iturriaga, Alfonso, Alejandro Pérez Cabeza, Josep Jové, et al.. (2016). The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort. Clinical & Translational Oncology. 18(10). 1026–1033. 3 indexed citations
13.
Torrecilla, J. López, A. Hervás, A. Zapatero, et al.. (2015). Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance. Reports of Practical Oncology & Radiotherapy. 20(4). 259–272. 13 indexed citations
14.
Cerezo, L., et al.. (2013). Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain. Clinical & Translational Oncology. 16(3). 301–306. 7 indexed citations
15.
Pardo, Yolanda, et al.. (2013). Quality of life impact of treatments for localized prostate cancer: A 7-year follow-up study. Reports of Practical Oncology & Radiotherapy. 18. S99–S99. 1 indexed citations
16.
Hervás, A., et al.. (2012). Nasopharyngeal mucoepidermoid carcinoma: A case report and review of literature. Reports of Practical Oncology & Radiotherapy. 18(2). 117–120. 7 indexed citations
17.
Hervás, A., et al.. (2010). Multidisciplinary management in rectal cancer. Clinical & Translational Oncology. 12(12). 805–818. 7 indexed citations
18.
Montero, Á., et al.. (2008). Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases. Clinical & Translational Oncology. 10(6). 334–346. 9 indexed citations
19.
Hervás, A., et al.. (2007). Calidad de vida relacionada con la salud en pacientes con diabetes mellitus tipo 2. Anales del Sistema Sanitario de Navarra. 30(1). 45–52. 56 indexed citations
20.
Hervás, A., et al.. (1990). [Aortico-left ventricular tunnel. Presentation of 2 new cases. Usefulness of non-invasive study].. PubMed. 43(2). 114–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfonso Mariño Breakdown of academic impact, for papers by Gemma Sancho Breakdown of academic impact, for papers by Jonn Wu Breakdown of academic impact, for papers by John W. Colberg Breakdown of academic impact, for papers by L. Cormier Breakdown of academic impact, for papers by P. Kil Breakdown of academic impact, for papers by S. Guérif Breakdown of academic impact, for papers by Ewa Szumacher Breakdown of academic impact, for papers by Göran Borghede Breakdown of academic impact, for papers by Mark S. Austenfeld
Rankless by CCL
2026